A
Acrivon Therapeutics (ACRV)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Acrivon Therapeutics (ACRV)
Acrivon Therapeutics, Inc. is a United States-based is a clinical-stage oncology therapeutics company. The Company provides technologies driving precision-based medicine. It leverages its phosphoproteomics technology called Acrivon Precision Predicti... Read more
- USD9.14
- USD9.14
- USD8.81
- USD25.47
- -23.70%
- --
- 4.68k
- 13.34k
- 206M
- 8.06
Stock News
2 hours ago
Dow Jones Futures: Market Correction Intensifies, S&P 500 Nears Key Level; Meta AI Push In Focus
Yahoo
2 hours ago
: Fed rate cuts could come sooner than expected, says former Goldman CEO Lloyd Blankfein
MarketWatch
yesterday
The Ratings Game: Could a break-up of Amazon be good for the stock? Analysts weigh in after FTC lawsuit.
MarketWatch
yesterday
Cramer says Amazon and Google stocks are still buys, despite antitrust lawsuits
CNBC
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
